Structural Formula (Buprenorphine Transdermal System 1)
Buprenorphine Patch, Extended Release
Product Images NDC 69238-1202
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 69238-1202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure E (Buprenorphine Transdermal System 10)
Figure F (Buprenorphine Transdermal System 11)
Figure G (Buprenorphine Transdermal System 12)
Figure H (Buprenorphine Transdermal System 13)
Figure I (Buprenorphine Transdermal System 14)
Figure J (Buprenorphine Transdermal System 15)
Figure K (Buprenorphine Transdermal System 16)
Figure L (Buprenorphine Transdermal System 17)
Figure M (Buprenorphine Transdermal System 18)
Figure N (Buprenorphine Transdermal System 19)
Figure 1: Cross-section (Buprenorphine Transdermal System 2)
This appears to be a technical description of a layered film for pharmaceuticals or medical use. The film consists of a backing layer, an overlapping adhesive film, a drug/polymer adhesive matrix, and a peel-off release liner. The purpose of the film may be to encapsulate medication or to deliver it to the skin.*
Figure O (Buprenorphine Transdermal System 20)
Figure P (Buprenorphine Transdermal System 21)
5 Mcg- Pouch (Buprenorphine Transdermal System 22)
This is a prescription medication known as Buprenorphine Transdermal System. It delivers 5 mcg per hour of buprenorphine for a period of 7 days to provide systemic relief from severe pain. This medication is not advised if the patient has intermittent pain or if the pain can be managed with other analgesics. It is important not to use it if there is a risk of breathing difficulties. The rest of the text appears to be corrupted and is not readable.*
5 Mcg- Carton (Buprenorphine Transdermal System 23)
This is information on the use and dosage of Buprenorphine Transdermal System, which contains 5 mg of buprenorphine and is applied to the skin. It is not recommended for the treatment of pain that can be treated with non-opioid medications or immediate-release opioids. It is packaged in a foil pouch with four transdermal systems and four disposal units. The typical dosage should be determined by reading the package insert. It is important to keep the product out of the reach of children.*
7.5 Mcg- Pouch (Buprenorphine Transdermal System 24)
This is a medication description for Buprenorphine Transdermal System used for systemic delivery of 7.5 mcg per hour of buprenorphine for seven days. However, it should not be used for pain that can be treated with immediate-release opioids or non-opioid analgesics. The package contains One (7.5 mcg/hr) Transdermal System. Some sections of the text are not available due to errors in the process.*
7.5 Mcg- Carton (Buprenorphine Transdermal System 25)
This is a medication description for Buprenorphine Transdermal System used to treat severe pain that can only be treated with an immediate-release opioid or non-opioid analgesic. The package includes four transdermal systems and four disposal units. Each system contains 7.5 mg of buprenorphine and is applied immediately upon removal from the foil pouch. Dosage and storage instructions are provided. The medication is manufactured by Amneal Pharma LLC and is delivered systemically at a rate of 7.5 mcg/hour for seven days.*
10 Mcg- Pouch (Buprenorphine Transdermal System 26)
This is a description of Buprenorphine Transdermal System, which delivers 10 mcg per hour of buprenorphine for seven days via a transdermal system. Users are advised not to use this system for pain that can be treated with immediate-release opioids or non-opioid analgesics and intermittent (on an as-needed basis) pain. The use of the system could result in serious or life-threatening breathing problems. The text also contains some codes, which are not relevant to the description.*
10 Mcg- Carton (Buprenorphine Transdermal System 27)
This is a description of a medication called Buprenorphine Transdermal System. It comes in a package of 4 disposal units and is available by prescription only. One transdermal system contains 10 mg of buprenorphine and delivers 10 mcg per hour for seven days. It should not be used for pain that can be treated with immediate-release opioids, non-opioid analgesics, or intermittent pain on an as-needed basis. Dosage information is available in the package insert, and the systems should be stored in an unopened foil pouch until ready to use. The medication is manufactured by Amneal Pharmaceuticals.*
15 Mcg- Pouch (Buprenorphine Transdermal System 28)
The text is a description of a medication called Buprenorphine Transdermal System, used for systemic delivery of 15 mcg per hour of buprenorphine for seven days. It includes a warning not to use the system for pain that can be treated with immediate-release opioids or non-opioid analgesics or intermittent pain. The rest of the text is not readable because it contains non-English characters.*
15 Mcg- Carton (Buprenorphine Transdermal System 29)
Buprenorphine Transdermal System should not be used for severe or life-threatening breathing problems. The system is not for pain treatment that can be treated with other medications or taken as needed. Each package contains 4 Disposal Units and one transdermal system which contains 15mg of buprenorphine. The systems should be stored in an unopened foil pouch until ready to use. The usual dosage should be followed, applying the system immediately upon removal from the pouch. The system is for systemic delivery of 15mg per hour of buprenorphine for seven days.*
Lk (Buprenorphine Transdermal System 3)
This is a study or experiment that involved the use of Buprenorphine Transdermal System of 10mcg/hour. There were 36 individuals involved and the system was applied every 7 days for a period of 3 times. The text also includes a chart with time (in days) as the x-axis and some unidentified data along the y-axis.*
20 Mcg- Pouch (Buprenorphine Transdermal System 30)
The text is a medication label for Buprenorphine Transdermal System. It delivers 20 mcg of buprenorphine per hour for seven days, which is used for chronic pain management. The label warns against using the system for pain that can be treated with immediate-release opioids. The text also contains NDC and RX numbers for reference.*
20 Mcg- Carton (Buprenorphine Transdermal System 31)
The text describes a medication, Buprenorphine Transdermal System, which comes in a package with four disposal units, and contains buprenorphine. This medication should not be used for pain that can be treated with other opioids or non-opioid medications, and is particularly dangerous in cases with serious or life-threatening breathing problems. Each system delivers 20 mcg per hour of buprenorphine for seven days. The medication should be stored at 20-25°C, and unusable if the seal on the pouch is broken. The manufacturer of this medication is Amneal Pharmaceuticals.*
Bh (Buprenorphine Transdermal System 4)
Yu (Buprenorphine Transdermal System 5)
This is a chart showing the "Percent of Reduction/improvement in Pain" for different "Supotins" and "Supartios" as well as an "LRThom S" treatment. The percentages range from 0% to 320%.*
Figure A (Buprenorphine Transdermal System 6)
Figure B (Buprenorphine Transdermal System 7)
Figure C (Buprenorphine Transdermal System 8)
Figure D (Buprenorphine Transdermal System 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
